Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Baxter
Cipla
UBS
Harvard Business School
Argus Health
Cerilliant
Accenture
Fish and Richardson
Farmers Insurance

Generated: October 19, 2017

DrugPatentWatch Database Preview

New River Company Profile

« Back to Dashboard

What is the competitive landscape for NEW RIVER, and what generic and branded alternatives to NEW RIVER drugs are available?

NEW RIVER has three approved drugs.



Summary for Applicant: New River

US Patents:0
Tradenames:7
Ingredients:3
NDAs:3
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
New River
TRIAVIL 2-25
amitriptyline hydrochloride; perphenazine
TABLET;ORAL014715-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
New River
DOXEPIN HYDROCHLORIDE
doxepin hydrochloride
CAPSULE;ORAL016987-003Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
New River
TRIAVIL 4-25
amitriptyline hydrochloride; perphenazine
TABLET;ORAL014715-005Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
New River
DOXEPIN HYDROCHLORIDE
doxepin hydrochloride
CAPSULE;ORAL016987-007Apr 13, 1987DISCNNoNo► Subscribe► Subscribe► Subscribe
New River
TRIAVIL 4-10
amitriptyline hydrochloride; perphenazine
TABLET;ORAL014715-003Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
New River
TRIAVIL 2-10
amitriptyline hydrochloride; perphenazine
TABLET;ORAL014715-004Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
New River
DOXEPIN HYDROCHLORIDE
doxepin hydrochloride
CAPSULE;ORAL016987-006Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
New River
TRIAVIL 4-50
amitriptyline hydrochloride; perphenazine
TABLET;ORAL014715-006Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
New River
DOXEPIN HYDROCHLORIDE
doxepin hydrochloride
CAPSULE;ORAL016987-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
New River
DOXEPIN HYDROCHLORIDE
doxepin hydrochloride
CAPSULE;ORAL016987-004Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for New River

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
New River
DOXEPIN HYDROCHLORIDE
doxepin hydrochloride
CAPSULE;ORAL016987-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
New River
TRIAVIL 2-25
amitriptyline hydrochloride; perphenazine
TABLET;ORAL014715-002Approved Prior to Jan 1, 1982► Subscribe► Subscribe
New River
DOXEPIN HYDROCHLORIDE
doxepin hydrochloride
CAPSULE;ORAL016987-006Approved Prior to Jan 1, 1982► Subscribe► Subscribe
New River
DOXEPIN HYDROCHLORIDE
doxepin hydrochloride
CAPSULE;ORAL016987-004Approved Prior to Jan 1, 1982► Subscribe► Subscribe
New River
TRIAVIL 4-25
amitriptyline hydrochloride; perphenazine
TABLET;ORAL014715-005Approved Prior to Jan 1, 1982► Subscribe► Subscribe
New River
TRIAVIL 4-50
amitriptyline hydrochloride; perphenazine
TABLET;ORAL014715-006Approved Prior to Jan 1, 1982► Subscribe► Subscribe
New River
DOXEPIN HYDROCHLORIDE
doxepin hydrochloride
CAPSULE;ORAL016987-002Approved Prior to Jan 1, 1982► Subscribe► Subscribe
New River
TRIAVIL 4-10
amitriptyline hydrochloride; perphenazine
TABLET;ORAL014715-003Approved Prior to Jan 1, 1982► Subscribe► Subscribe
New River
DOXEPIN HYDROCHLORIDE
doxepin hydrochloride
CAPSULE;ORAL016987-003Approved Prior to Jan 1, 1982► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
Moodys
Cantor Fitzgerald
Argus Health
AstraZeneca
Deloitte
Healthtrust
Julphar
Chinese Patent Office
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot